About Glooko
Glooko is a company based in Palo Alto (United States) founded in 2010. Glooko has raised $201 million across 8 funding rounds from investors including Medtronic, Insulet and Health Catalyst. Glooko has completed 3 acquisitions, including Diasend, Monarch Medical Technologies and xbird. Glooko operates in a competitive market with competitors including BeatO, Health2Sync, Dr. Diary Co, SocialDiabetes and Tidepool, among others.
- Headquarter Palo Alto, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Glooko
Unlock access to complete
Unlock access to complete
Software Development Team
23 people
Leadership Team
19 people
Product Management Team
15 people
Sales and Marketing
8 people
Senior Team
5 people
Data Analysis and Operations Team
5 people
Finance and Accounting
3 people
Customer Team
3 people
Unlock access to complete
Funding Insights of Glooko
Glooko has successfully raised a total of $201M across 8 strategic funding rounds. The most recent funding activity was a Series F round of $100 million completed in October 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Glooko
Glooko has secured backing from 23 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include Medtronic, Insulet and Health Catalyst.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital is provided to expanding B2B software companies.
|
Locked | Locked | Locked | |
|
Canaan is recognized as an early-stage venture capital firm.
|
Locked | Locked | Locked | |
|
Growth-stage US tech companies are funded by Health Catalyst Capital.
|
Locked | Locked | Locked |
Investor details for Glooko
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Glooko
Glooko has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include Diasend, Monarch Medical Technologies and xbird.
Investment portfolio details for Glooko
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Provider of AI-based solutions for diagnosis and health risk assessment
|
Locked | Locked | 2015 | Locked | |
|
Web and mobile solution for diabetic patients
|
Locked | Locked | 2005 | Locked | |
|
Clinical decision support software for inpatient glucose management is provided.
|
Locked | Locked | 2003 | Locked |
Complete acquisition details for Glooko
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Glooko
Detailed financials for Glooko
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Glooko Comparisons
Peer comparison for Glooko
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Glooko
Glooko operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as BeatO, Health2Sync, Dr. Diary Co, SocialDiabetes and Tidepool, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Smartphone-enabled glucometers and diabetes management apps are provided.
|
|
| Locked | Locked | Locked |
Provider of an app for tracking blood glucose level
|
|
| Locked | Locked | Locked |
Provider of app for diabetes management
|
|
| Locked | Locked | Locked |
Mobile health solution that connects doctors and diabetic patients
|
|
| Locked | Locked | Locked |
SaaS for Type 1 diabetes management is provided by Tidepool.
|
Detailed competitors of Glooko
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Glooko
Complete news archive for Glooko
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Glooko
Glooko was founded in 2010 and raised its 1st funding round 1 year after it was founded.
Glooko is headquartered in Palo Alto, United States. It is registered at Palo Alto, California, United States.
Mike Alvarez is the current CEO of Glooko.
Glooko is a funded company, having raised a total of $201M across 8 funding rounds to date.
Glooko is a diabetes management solution for patients, health systems, and payer groups. Glookos products enable clinicians to remotely access their patients blood glucose readings and other related data, and optimize their insulin therapy. The companys System allows people with diabetes to download their glucose readings to their mobile devices. According to the company, their population management web app offers diabetes-centric analytics and supplies insightful reports, graphs and pattern-triggered notifications to patients, health systems and payers. Partners include Abbott, Roche, LifeScan, Medtronic, Omnipod, Bayer, Nipro, and Arkray among others. Glooko and Diasend got merged in September 2016 and the combined companies operate under the Glooko moniker.
Glooko's top competitors include BeatO, Health2Sync and SocialDiabetes.
Glooko has made 3 acquisitions, including Diasend, Monarch Medical Technologies, and xbird.
Glooko has 23 investors. Key investors include Medtronic, Insulet, Health Catalyst, Novo Nordisk, and Mayo Clinic.